Related Experiment Video
Updated: Jul 30, 2025

Author Spotlight: Developing Parmodulins to Target Protease-Activated Receptors for Inflammation Control
Published on: May 24, 2024
Species Differences in Platelet Protease-Activated Receptors
Stephanie A Renna1, Steven E McKenzie1, James V Michael1
1Department of Medicine, The Cardeza Foundation for Hematologic Research, Thomas Jefferson University, Philadelphia, PA 19107, USA.
Protease-activated receptors (PARs) are key to blood clotting and anti-platelet drug targets. This review details mouse-human PAR differences and new tools for studying human PARs in mice.
Area of Science:
- Biochemistry
- Pharmacology
- Physiology
Background:
- Protease-activated receptors (PARs) are integral membrane proteins activated by proteases like thrombin.
- PARs play crucial roles in platelet function, hemostasis, and thrombosis.
- PARs are significant targets for developing anti-platelet therapies.
Purpose of the Study:
- To summarize PAR expression and functional differences between mice and humans.
- To highlight novel tools for investigating human PAR physiology in mouse models.
Main Methods:
- Comparative analysis of PAR expression and function in mouse and human systems.
- Review of recently developed research tools and methodologies.
Main Results:
- Significant differences exist in PAR expression and function between mouse and human platelets.
- Existing genetically modified mouse models have limitations for studying human PAR physiology.
- New tools offer improved approaches for in vivo human PAR research using mouse models.
Conclusions:
- Understanding mouse-human PAR differences is critical for translating findings from animal models to human therapies.
- Advanced tools are emerging to better model human PAR-related diseases and test anti-platelet drugs in preclinical settings.
Related Concept Videos
Formation of the Platelet Plug
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Structure and Function of Platelets
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...

